» Articles » PMID: 33967022

Pain, Symptom Distress, and Pain Barriers by Age Among Patients with Cancer Receiving Hospice Care: Comparison of Baseline Data

Overview
Journal J Geriatr Oncol
Publisher Elsevier
Specialty Geriatrics
Date 2021 May 10
PMID 33967022
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Age group differences have been reported for pain and symptom presentations in outpatient and inpatient oncology settings, but it is unknown if these differences occur in hospice. We examined whether there were differences in pain, symptom distress, pain barriers, and comorbidities among three age groups (20-64 years, 65-84 years, and 85+) of hospice patients with cancer.

Materials And Methods: Participants were recruited from two hospices. Half were women; 49% White and 34% Black. 42% were 20-64 y, 43% 65-84 y, and 15% 85+ y. We analyzed baseline data for 230 hospice patients with cancer (enrolled 2014-2016, mean age 68.2 ± 14.0, 20-100 years) from a stepped-wedge randomized controlled trial. Measures were the Average pain intensity (API, 0-10: current, least and worst pain intensity during the past 24 h), Symptom Distress Scale (SDS, 13-65), Barriers Questionnaire-13 (BQ-13, 0-5), and comorbid conditions. Descriptive, bivariate association, and multiple regression analyses were performed.

Results: Mean API scores differed (p < .001) among the three age groups (5.6 ± 2.0 [20-64 years], 4.7 ± 2.0 [65-84 years], and 4.4 ± 1.8 [85+], as did the mean SDS scores (36.1 ± 7.3, 33.5 ± 8.1, and 31.6 ± 6.6, p = .004). BQ-13 mean scores (2.6 ± 0.9, 2.7 ± 0.8, and 2.5 ± 0.7) and comorbidities were not significantly different across age groups. In multiple regression analyses, age-related differences in API and SDS remained significant after adjusting for gender, race, cancer, palliative performance score, and comorbidities. Comorbidities were positively associated with SDS (p = .046) but not with API (p = .64) in the regression model.

Conclusion: Older hospice patients with cancer reported less pain and symptoms than younger patients, but all groups reported similar barriers to pain management. These findings suggest the need for age- and race-sensitive interventions to reduce pain and symptom distress levels at life's end.

Citing Articles

Validation of the tablet-based Turkish-PAINReportIt® for lung cancer patients after thoracotomy in Turkey.

Erden S, Karacay Yikar S, Dogan S, Lucero R, Yildiz K, Gezer S Appl Nurs Res. 2023; 70:151673.

PMID: 36933901 PMC: 10257141. DOI: 10.1016/j.apnr.2023.151673.


Geriatrics communication skills training program for oncology healthcare providers to improve the management of care for older adults with cancer.

Rosa W, Cannity K, Moreno A, Cardillo C, Schofield E, Korc-Grodzicki B PEC Innov. 2023; 1.

PMID: 36741338 PMC: 9894477. DOI: 10.1016/j.pecinn.2022.100066.

References
1.
Jensen M, Karoly P, Braver S . The measurement of clinical pain intensity: a comparison of six methods. Pain. 1986; 27(1):117-126. DOI: 10.1016/0304-3959(86)90228-9. View

2.
Wilkie D, Yao Y, Ezenwa M, Suarez M, Dyal B, Gill A . A Stepped-Wedge Randomized Controlled Trial: Effects of eHealth Interventions for Pain Control Among Adults With Cancer in Hospice. J Pain Symptom Manage. 2019; 59(3):626-636. DOI: 10.1016/j.jpainsymman.2019.10.028. View

3.
Turnheim K . When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol. 2003; 38(8):843-53. DOI: 10.1016/s0531-5565(03)00133-5. View

4.
Edrington J, Sun A, Wong C, Dodd M, Padilla G, Paul S . Barriers to pain management in a community sample of Chinese American patients with cancer. J Pain Symptom Manage. 2008; 37(4):665-75. PMC: 2688466. DOI: 10.1016/j.jpainsymman.2008.04.014. View

5.
Nolen S, Evans M, Fischer A, Corrada M, Kawas C, Bota D . Cancer-Incidence, prevalence and mortality in the oldest-old. A comprehensive review. Mech Ageing Dev. 2017; 164:113-126. PMC: 7788911. DOI: 10.1016/j.mad.2017.05.002. View